ClinicalTrials.Veeva

Menu

Dermal Wound Closure Using Silkam® (DERMASILK)

Aesculap logo

Aesculap

Status

Enrolling

Conditions

Contusions
Incision
Laceration

Study type

Observational

Funder types

Industry

Identifiers

NCT05225714
AAG-O-H-1929

Details and patient eligibility

About

Assessment of performance of Silkam® suture material for skin closure. A prospective, single center, single arm, observational study in daily practice.

Full description

The prospective, monocentric, single-arm, observational Post Market Clinical Follow-Up (PMCF) study is done to continue to evaluate the safety and performance of Silkam® suture material for skin closure under clinical routine. Safety and effectiveness parameters commonly used in skin closure are to be used to evaluate the performance of the suture material.

The aim of this Non Interventional Study is to collect systematically and proactively different clinical parameters regarding safety, effectiveness and performance of Silkam® suture material under the daily routine clinical practice when used for skin closure as intended.

Enrollment

164 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult and paediatric patients undergoing skin closure using Silkam® as suture material.
  • Written informed consent regarding the data collection for the PMCF study.

Exclusion criteria

  • Pregnancy
  • Visible dirty wounds
  • Patients taking medication that might affect wound healing
  • Patients with hypersensitivity or allergy to the suture material

Trial contacts and locations

1

Loading...

Central trial contact

Joan Lluis Pérez Moreno; José Manuel M Molina Villar, Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems